What Is a Feasibility Study?
A feasibility study asks whether a planned study or intervention can be carried out, and under what conditions, before a full study is designed. It is broader than a pilot: it may examine whether the research question is worth pursuing, whether the intervention is acceptable, and whether the resources exist.
Feasibility versus pilot
Authors use these terms differently. A common distinction is:
- Feasibility study: asks whether the main study can be done (can we recruit, measure, retain participants; is the intervention acceptable?). It may not use the planned design.
- Pilot study: a smaller version of the main study that runs the same procedures, including randomisation if the main study is a trial.
Always define what you mean in your protocol and report.
Typical questions
| Area | Example questions |
|---|---|
| Recruitment | How many eligible patients are there? What proportion agree? |
| Procedures | Can staff deliver the intervention as designed? |
| Measurement | Are data complete and reliable? |
| Acceptability | Do participants and staff find it acceptable? |
| Resources | What time, staff and cost are needed? |
Illustrative example
Invented for teaching. A research team wants to run a trial of a telephone-based diabetes coaching programme. A feasibility study interviews 15 patients and 5 nurses, records how many patients are eligible in clinic, and tests the coaching scripts for 6 weeks. It finds that evening calls are preferred and that a third of patients lack a reliable phone, which informs the design of the trial.
Common pitfalls
- Using "feasibility" to justify a small, underpowered study of effectiveness.
- Not defining success criteria in advance.
Key takeaways
- The question is "can it be done?", not "does it work?".
- Mixed methods (numbers and interviews) are often useful.
- Define progression criteria beforehand.
References and further reading
- Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing Clinical Research. 4th ed. Lippincott Williams & Wilkins; 2013. Link
- Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi:10.1136/bmj.c332
- Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200-207. doi:10.7326/0003-4819-158-3-201301080-00007
Related reading
This page is general educational information about research methods. It is not medical, legal or regulatory advice; follow your institution's ethics board and your target journal's instructions.
